Company / Cash per Share
Arbutus Biopharma Corp Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.09
FY2025
5-year range
$0.09 / $1.22
FY2021-FY2025
Trend
-55.7%
vs FY2024
Sector context
#200 of 205
Health Care
What the data says
Among 205 Health Care companies, Arbutus Biopharma Corp is in the bottom 2% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $0.09 in FY2025 to $1.22 in FY2021.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of -34.8%.
Declined from $0.17 to $0.09 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -23.6%
- 5-Year CAGR
- -34.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 205This company $0.09 Sector average $72.93
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 55.7% year-over-year.
- Ranks #200 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | -55.7% |
| FY2024 | $0.21 | +28.1% |
| FY2023 | $0.17 | -21.4% |
| FY2022 | $0.21 | -82.6% |
| FY2021 | $1.22 | +51.1% |
| FY2020 | $0.81 | +40.8% |
| FY2019 | $0.57 | -41.9% |
| FY2018 | $0.99 | +0.0% |
| FY2017 | $0.99 | +131.0% |
| FY2016 | $0.43 | -86.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026